Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder

Kenneth A Myers1, Carla Marini1, Gemma L Carvill1

  • 1Research Institute of the McGill University Health Centre (K.M.), Montreal, PQ; Division of Child Neurology (K.M.), Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, PQ; Department of Neurology & Neurosurgery (K.M.), Montreal Children's Hospital, McGill University, Montreal, PQ; Child Neurology and Psychiatry (C.M.), Salesi Pediatric Hospital, United Hospitals of Ancona, Ancona, Italy; Division of Genetic Medicine (G.L.C., J.N., H.C.M.), Department of Pediatrics, University of Washington, Seattle, WA; Department of Neurology (A.M.), Great Ormond Street Hospital for Children, London, UK; Developmental Neurosciences Programme (A.M.), UCL Great Ormond Street Institute of Child Health, London, UK; Neurology Network Melbourne (J.P.), Melbourne, Victoria, Australia; Murdoch Children's Research Institute (C.S., I.E.S.), Parkville, Victoria, Australia; Department of Paediatrics and Child Health (T.S.), School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; Division of Neurology (S.M.), Department of Pediatrics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Neurology Unit and Neurogenetic Laboratories (C.B., A.R., R.G.), Meyer Children's Hospital, Florence, Italy; Department of Clinical Genetics (R.H.S.), Great Ormond Street Hospital, London, UK; Epilepsy Research Centre (I.E.S.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia; Department of Paediatrics (I.E.S.), Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia; and The Florey Institute of Neuroscience and Mental Health (I.E.S.), Heidelberg, Victoria, Australia.

Neurology. Genetics
|April 29, 2021
PubMed
Abstract

Insights

MBD5-associated neurodevelopmental disorder (MAND) often presents with severe early-onset epilepsy and developmental delays. Neuropsychiatric issues like aggression and sleep disturbances are common and require clinical attention.

Area of Science:

  • Genetics
  • Neuroscience
  • Pediatrics

Background:

  • MBD5-associated neurodevelopmental disorder (MAND) is a rare genetic condition.
  • Phenotypic variability exists among affected individuals.

Purpose of the Study:

  • To delineate the phenotypic spectrum of MAND, focusing on patients with seizures.
  • To understand the clinical manifestations and management challenges in MAND.

Main Methods:

  • Phenotypic characterization of 23 patients with MBD5 genetic alterations (deletions, duplications, point mutations) and a history of seizures.
  • Analysis of seizure types, onset, EEG findings, developmental impairment, and behavioral issues.

Main Results:

  • Seizures, predominantly generalized tonic-clonic, began in early childhood (median 2.9 years).
  • Moderate-to-severe developmental impairment and behavioral problems (aggression, self-injury, sleep disturbance) were prevalent.
  • Epilepsy syndromes like Lennox-Gastaut and infantile spasms were observed; some cases showed drug resistance.

Conclusions:

  • MBD5 disruption is linked to severe early-onset developmental and epileptic encephalopathy.
  • Neuropsychiatric dysfunction is a significant and common feature requiring focused clinical management.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
871
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
686
Pedigree Analysis01:35

Pedigree Analysis

Overview
87.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
484